Interleukin-10 promoter polymorphism is associated with the predisposition to the development of IgA nephropathy and focal segmental glomerulosclerosis in Korea

Journal of Korean Medical Science

Volumn 20, Issue 6, 2005, Pages 989-993

  Ho, Jun Chin ^b   Ki, Young Na ^b   Soo, Jin Kim ^b   Oh, Kook Hwan ^a   Yon, Su Kim ^b   Chun, Soo Lim ^b   Kim, Suhnggwon ^b   Chae, Dong Wan ^b,c  

^a Hallym University College of Medicine   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Seoul National University Bundang Hospital   (South Korea)

Author keywords

Glomerulonephritis, IGA; Glomerulosclerosis, focal; Polymorphism; Single Nucleotide

Indexed keywords

EID: 31544481390     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2005.20.6.989     Document Type: Article

References (33)

1. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001; 19: 683-765.
2. Tipping PG, Kitching AR, Huang XR, Mutch DA, Holdworth SR. Immune modulation with interleukin-4 and interleukin-10 prevents crescent formation and glomerular injury in experimental glomerulonephritis. Eur J Immunol 1997; 27: 530-7.
3. Kitching AR, Tipping PG, Timoshanko JR, Holdsworth SR. Endogenous interleukin-10 regulates Th1 response that induce crescentic glomerulonephritis. Kidney Int 2002; 57: 518-25.
4. El-Shemi AG, Fujinaka H, Matsuki A, Kamiie J, Kovalenko P, Qu Z, Bilim V, Nishimoto G, Yaoita E, Yoshida Y, Anegon I, Yamamoto T. Suppression of experimental crescentic glomerulonephritis by interleukin-10 gene transfer. Kidney Int 2004; 65: 1280-9.
5. Higuchi N, Maruyama H, Kuroda T, Kameda S, Iino N, Kawachi H, Nishikawa Y, Hanawa H, Tahara H, Miyazaki J, Gejyo F. Hydrodynamics-based delivery of the viral interleukin-10 gene suppresses experimental crescentic glomerulonephritis in Wistar-Kyoto rats. Gene Ther 2003; 10: 1297-310.
6. Huang XR, Kitching AR, Tipping PG, Holdworth SR. Interleukin-10 inhibits macrophage-induced glomerular injury. J Am Soc Nephrol 2000; 11: 262-9.
7. Kitching AR, Katerelos M, Mudge SJ, Tipping PG, Power DA, Holdsworth SR. Interleukin-10 inhibits experimental mesangial proliferative glomerulonephritis. Clin Exp Immunol 2002; 128: 36-43.
8. Choi YK, Kim YJ, Park HS, Choi K, Paik SG, Lee YI, Park JG. Suppression of glomerulosclerosis by adenovirus-mediated IL-10 expression in the kidney. Gene Ther 2003; 10: 559-68.
9. Yin Z, Bahtiyar G, Zhang N, Liu L, Zhu P, Robert ME, McNiff J, Madaio MP, Craft J. IL-10 regulates murine lupus. J Immunol 2002; 169: 2148-55.
10. Chadban SJ, Tesch GH, Foti R, Atkins RC, Nikolic-Paterson DJ. Interleukin-10 is a mesangial cell growth factor in vitro and in vivo. Lab Invest 1997; 76: 619-27.
11. Chadban SJ, Tesch GH, Lan HY, Atkins RC, Nikolic-Paterson DJ. Effect of interleukin-10 treatment on crescentic glomerulonephritis in rats. Kidney Int 1997; 51: 1809-17.
12. Chadban SJ, Tesch GH, Foti R, Lan HY, Atkins RC, Nikolic-Paterson DJ. Interleukin-10 differentially modulates MHC class II expression by mesangial cells and macrophages in vitro and in vivo. Immunology 1998; 94: 72-8.
13. Ishida H, Muchamuel T, Sakaguchi S, Andrade S, Menon S, Howard M. Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice. J Exp Med 1994; 179: 305-10.
14. Niemir ZI, Ondracek M, Dworacki G, Stein H, Waldherr R, Ritz E, Otto HF. In situ upregulation of IL-10 reflects the activity of human glomerulonephritides. Am J Kidney Dis 1998; 32: 80-92.
15. Lim CS, Zheng S, Kim YS, Ahn C, Han JS, Kim S, Lee JS, Chae DW, Koo JR, Chun RW, Noh JW. Th1/Th2 predominance and proinflammatory cytokines determine the clinicopathological severity of IgA nephroapathy. Nephrol Dial Transplant 2001; 16: 269-75.
16. Eskdale J, Kube D, Tesch H, Gallagher G. Mapping of the human IL-10 gene and further characterization of the 5′ flanking sequence. Immunogenetics 1997; 46: 120-8.
17. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of poplymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997; 24: 1-8.
18. Tagore A, Gonsalkorale WM, Pravica V, Hajeer AH, McMahon R, Whorwell PJ, Sinnott PJ, Hutchinson IV. Interleukin-10 (IL-10) genotypes in inflammatory bowel disease. Tissue Antigens 1999; 54: 386-90.
19. Hajeer AH, Lazarus M, Turner D, Mageed RA, Vencovsky J, Sinnott P, Hutchinson IV, Ollier WE. IL-10 gene promoter polymorphisms in rheumatoid arthritis. Scand J Rheumatol 1998; 27: 142-5.
20. Mok CC, Lanchbury JS, Chan DW, Lau CS. Interleukin-10 promoter polymorphisms in southern Chinese patients with systemic lupus erythematosus. Arthritis Rheum 1998; 41: 1090-5.
21. Sankaran D, Asderakis A, Ashraf S, Roberts IS, Short CD, Dyer PA, Sinnott PJ, Hutchinson IV. Cytokine gene polymorphisms predict acute graft rejection following renal transplantation. Kidney Int 1999; 56: 281-8.
22. Park SH, Kang KJ, Song YR, Chae D-W, Oh KH, Kim SG, Noh JW, Lee YK, Lim CS, Kim YS, Kim S. The impact of gene polymorphism of interleulin-10 and interferon-gamma on the clinical courses of renal transplant patients in Korea. Korean J Nephrol 2002; 21: 990-9.
23. Lee JP, Ro H, Yang JS, Ha J, Kim SJ, Chae DW, Ahn C, Han JS, Kim S, Lee JS. Single center study about post-transplant anemia (PTA) in Korean transplant recipients: prevalence and risk factors for PTA. J Korean Soc Transplant 2004; 18: 144-54.
24. Edwards-Smith CJ, Jonsson JR, Purdie DM, Bansal A, Shorthouse C, Powell EE. Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa. Hepatology 1999; 30: 526-30.
25. Reynard MP, Turner D, Navarrete CV. Allele frequencies of polymorphisms of the tumor necrosis factor-α, interleukin-10, interferon-γ and interleukin-2 genes in a North European Caucasoid group from the UK. Eur J Immunogenet 2000; 27: 241-9.
26. Cartwright NH, Keen LJ, Demaine AG, Hurlock NJ, McGonigle RJ, Rowe PA, Shaw JF, Szydlo RM, Kaminski ER. A study of cytokine gene polymorphisms and protein secretion in renal transplantation. Transpl Immunol 2001; 8: 237-44.
27. Rosenwasser LJ, Borish L. Genetics of atopy and asthma: The rationale behind promoter-based candidate gene studies (IL-4 and IL-10). Am J Respir Crit Care Med 1997; 156: 152-5.
28. Perrey C, Pravica V, Sinnott PJ, Hutchinson IV. Genotyping for polymorphisms in interferon-γ, interleukin-10, transforming growth factor-β1 and tumor necrosis factor-α genes: a technical report. Transpl Immunol 1998; 6: 193-7.
29. Turner DM, Williams DM, Sankarah D, Lazarus M, Sinnot PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997; 24: 1-8.
30. Bantis C, Heerring PJ, Aker S, Klein-Vehne N, Grabensee B, Ivens K. Association of interleukin-10 gene G-1082A polymorphism with the progression of primary glomerulonephritis. Kideny Int 2004; 66: 288-94.
31. Medcraft J, Hitman GA, Sachs JA, Whichelow CE, Raafat I, Moore RH. Autoimmune renal disease and tumor necrosis factor beta gene polymorphism. Clin Nephrol 1993; 40: 63-8.
32. Freedman BI, Yu H, Spray BJ, Rich SS, Rothschild CB, Bowden DW. Genetic linkage analysis of growth factor loci and end-stage renal disease in African Americans. Kidney Int 1997; 51: 819-25.
33. Shu KH, Lee SH, Cheng CH, Wu MJ, Lian JD. Impact of interleukin-1 receptor antagonist and tumor necrosis factor-alpha gene polymorphism on IgA nephropathy. Kidney Int 2000; 58: 783-9.